Philips seals MRI software deal with iCAD; Japan establishes guidelines for fetal abnormalities blood test;

 @FierceMedDev: In the wake of BrainGate, Brown U. debuts wireless brain sensor. Editor's Corner | Follow @FierceMedDev

 @MarkHFierce: Robert White, CEO of Fierce 15 company Tyrx, is joining AtriCure's board of directors. Interesting development. News | Follow @MarkHFierce

 @DamianFierce: In case you missed it over the weekend, J&J has to shell out $8.3M in its first all-metal hip trial. Article | Follow @DamianFierce

> AtriCure ($ATRC), maker of surgical ablation devices to treat atrial fibrillation, has appointed Tyrx CEO Robert White to its board of directors. Release

> Philips Healthcare's Invivo and iCAD will jointly develop next-generation prostate and breast imaging MRI software and technology. Release

> Japan now has formal guidelines in place to use Sequenom's blood test designed to detect fetal chromosomal abnormalities that can lead to conditions such as Down syndrome. Story

> Germany's invendo medical has entered the U.S. market with a new single-use, computer-assisted, hand-held colonoscope, following 510(k) clearance of a number of improvements on the device. Release

> It turns out hybrid or electric cars have no effect on an implantable cardioverter-defibrillator, according to a new Mayo Clinic study. Story

Biotech News

 @FierceBiotech: Popular last week: Ex-Amgen research czar Perlmutter to helm Merck's struggling R&D ops. Article | Follow @FierceBiotech

@JohnCFierce: Sanford-Burnham and Mayo Clinic to collab on drug pipeline. Release | Follow @JohnCFierce

@RyanMFierce: The salesforce.com of pharma is seeking an IPO, Bloomberg reported. Veeva makes sense: Story | Follow @RyanMFierce

> Leading industry backlash, AbbVie counterattacks on move to unlock Humira data. Report

> U.K. Catalyst fund injects $70M into new generation of biotechs. Story

> Medicines Co.'s blood thinner finally reaps positive results in third PhIII. More

Pharma News

@FiercePharma: The U.S. taxman may come for pharma's foreign profits. Merck, J&J, Pfizer among those saving tax $$. Article | Follow @FiercePharma

@EricPFierce: Baxter to cut 400 jobs in Puerto Rico amid plant upgrades. Expansion includes 1 that FDA cited 2 years ago. News | Follow @EricPFierce

> Reports: Ex-Novartis chief Vasella to flee Switzerland for US. Item

> DoJ probes Sanofi disclosures on Plavix effectiveness. Story

CRO News

> Report: Only 45 Indian trial deaths compensated since 2005. More

> WuXi predicts more double-digit growth in 2013. Story

> Patheon's loss widens after $255M Banner deal. Report

> PRA buys ClinStar, expands in Eastern Europe. News

Biotech IT News

> Brown marries brains and computers. Item

> U.S. and Israeli groups team to sync medical, clinical trials software. News

> Microsoft's web-search mining uncovers side effect of drug pairing. Story

> Facebook goes biotech for new board member. Article

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.